An Open-Label Single-Arm, Phase Ii Trial of Zalutumumab, a Human Monoclonal Anti-Egfr Antibody, in Patients with Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck
49Th Annual Meeting of the American-Society-Of-Clinical-Oncology (Asco), Date: MAY 31-JUN 04, 2013, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol
